LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Vending & Kiosk Businesses for Sale
Coffee Shop, Bakery & Dessert Businesses for Sale
Wholesale & Distribution Businesses for Sale
Furniture & Home Decor Businesses for Sale
Healthcare & Medical Businesses for Sale
Restaurants for Sale
Pet Businesses for Sale
Miscellaneous Businesses for Sale
Warehouse & Storage Businesses for Sale
Dollar Stores for Sale
Employment & Personnel Franchise Opportunities
Entertainment & Recreation Franchise Opportunities
Coffee, Bakery & Dessert Franchise Opportunities
Construction & Landscaping Franchise Opportunities
Environmental Franchise Opportunities
Child Care & Education Franchise Opportunities
Home Based Franchise Opportunities
Vending & Kiosk Franchises for Sale
Finance & Accounting Franchise Opportunities
Manufacturing Franchises for Sale
Commercial Spaces for Sale or Lease
Land & Developments for Sale
Plazas for Sale
Industrial Buildings for Sale or Lease
Houses & Condos for Sale or Lease
Places of Worship for Sale
Medical Office Spaces for Sale or Rent
Commercial Buildings for Sale or Lease
Apartment Buildings for Sale
Medical Buildings for Sale or Lease
An email will be sent to registered email address.
Please select if you are: